TrialScanner: Clinical Trials

TrialScanner follows the clinical trials run by US-listed biotech and pharmaceutical companies, straight from the public ClinicalTrials.gov registry. Sponsors register their trials on ClinicalTrials.gov and update each record as the trial moves: phase, recruiting status, enrollment and the dates they expect to finish. Those records are public but hard to follow company by company. TrialScanner links each trial to its sponsor's stock and records what changes. WHAT YOU CAN DO - Browse a calendar of registered primary completion dates for trials sponsored by listed companies, labelled as the sponsor's estimate. - Filter the calendar by phase, recruiting status, time window and ticker. - Open a company to see the trials it sponsors, by phase and status. - Open a trial to see its registry record: sponsor, conditions, phase, status and dates. - Open a drug to see the trials that test it. - Follow the feed of registry changes: status changes, moved completion dates and results first posted. - Search any trial, stock or drug. FREE AND PRO Free, with no account needed: every tracked trial with its NCT id, title, phase, registry status, sponsor and conditions; the registered primary completion date; trial, ticker and drug pages; the new value of each recorded change; and the calendar up to 90 days ahead. TrialScanner Pro adds enrollment and interventions for every trial, start and completion dates, results posting, previous values and full change histories, the calendar up to a year ahead, and following trials, drugs and stocks in the app. ABOUT THE DATA Trial records come from ClinicalTrials.gov, run by the US National Library of Medicine. Dates in a record are the sponsor's estimates and often move. A change to a trial record is a fact about the registry, not a forecast of the trial's result, of a regulatory decision or of a stock price. TrialScanner is not affiliated with or endorsed by ClinicalTrials.gov, the National Library of Medicine, NIH, the FDA or any sponsor. SUBSCRIPTION TrialScanner Pro costs $9.99 per month, billed through Google Play. It renews automatically each month until you cancel it in Google Play (Play Store > Payments and subscriptions > Subscriptions). IMPORTANT TrialScanner is a research and information tool about public companies. It is not medical advice: it does not diagnose, treat or recommend anything, and it is not a way to find or enroll in a trial. Talk to a doctor about any medical question. It is also not investment advice, a recommendation to buy or sell any security, or an offer of any kind, and it is not a broker. Data can be delayed, incomplete or wrong; check the registry record before relying on it. TrialScanner is made by Signal8.

First release.